
Developer of gene-edited crop traits spun out of Cellectis.
Industry: Health Care
First Day Return: +40.6%
Industry: Health Care

| IPO Data | |
|---|---|
| IPO File Date | 06/23/2017 |
| Offer Price | $8.00 |
| Price Range $8.00 - $10.00 | |
| Offer Shares (mm) | 7.0 |
| Deal Size ($mm) | $56 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 07/19/2017 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $56 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | New Brighton, MN, United States |
| Founded | 2010 |
| Employees at IPO | 27 |
| Website www.calyxt.com | |